Clinical Research Directory
Browse clinical research sites, groups, and studies.
MRg-NIRS Imaging System Breast Cancer Trial
Sponsor: Keith D. Paulsen
Summary
This trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).
Official title: Evaluation of the Magnetic Resonance-guided (MRg) Near-infrared Spectroscopy (NIRS) Imaging System Platform in Breast Cancer Patients
Key Details
Gender
FEMALE
Age Range
18 Years - 83 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-09-23
Completion Date
2027-03-31
Last Updated
2025-11-24
Healthy Volunteers
No
Conditions
Interventions
MRg-NIRS
The trial tests the investigator designed and developed Magnetic Resonance-guided (MRg) Near-infrared Spectroscopy (NIRS) imaging system for breast cancer detection. The wearable NIRS imaging system uses 8 flex circuit strips, each with six photo-detectors (PDs) and six source fibers, that are ready to attach to a breast radially by using an adhesive nipple cover and breast tape.
Locations (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States